Cargando…
Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
PURPOSE: Early improvement in major depressive disorder is defined as a reduction of ≥20% in the 17-item Hamilton Depression Rating Scale (HAM-D-17) score at the second week after initiation of treatment, predicting long-term treatment response. However, there remains no effective strategy for switc...
Autores principales: | Yuan, Hsinsung, Zhu, Xiao, Luo, Qiang, Halim, Alice, Halim, Michael, Yao, Hao, Cai, Yiyun, Shi, Shenxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586220/ https://www.ncbi.nlm.nih.gov/pubmed/31354272 http://dx.doi.org/10.2147/NDT.S196533 |
Ejemplares similares
-
The change of gut microbiota in MDD patients under SSRIs treatment
por: Shen, Yang, et al.
Publicado: (2021) -
The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
por: Papalexi, E., et al.
Publicado: (2021) -
Early improvement of painful symptoms in MDD: is there an association in achieving remission?
por: Bär, Karl-Jürgen
Publicado: (2007) -
Findings from real-world clinical practice on tDCS treatment of MDD
por: Panhelainen, A.
Publicado: (2023) -
The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)